Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Pamela McLawhon"'
Autor:
Pamela McLawhon, Adrian J. Fretland, Peter N. Morcos, Micaela B. Reddy, Alyson Connor, Amy S. Zhou, Jonathan Q. Tran, Patrick F. Smith, Philip Evans, Barbara J. Brennan
Publikováno v:
Biopharmaceutics & Drug Disposition. 32:261-275
Danoprevir, a potent, selective inhibitor of HCV NS3/4A protease, has a short half-life in humans. Therefore, the feasibility of a controlled release (CR) formulation to allow less frequent dosing was investigated using experimental approaches and ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86dd317d292a1495fb1b92be5de8de5a
https://doi.org/10.1002/bdd.756
https://doi.org/10.1002/bdd.756
Autor:
Micaela B, Reddy, Alyson, Connor, Barbara J, Brennan, Peter N, Morcos, Amy, Zhou, Pamela, McLawhon, Adrian, Fretland, Philip, Evans, Patrick, Smith, Jonathan Q, Tran
Publikováno v:
Biopharmaceuticsdrug disposition. 32(5)
Danoprevir, a potent, selective inhibitor of HCV NS3/4A protease, has a short half-life in humans. Therefore, the feasibility of a controlled release (CR) formulation to allow less frequent dosing was investigated using experimental approaches and ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::48dcebdab1e9942befb86349674167bc
https://pubmed.ncbi.nlm.nih.gov/21660978
https://pubmed.ncbi.nlm.nih.gov/21660978